Bioagent Characterization by Iterative Extension
Bioagent Characterization by Iterative Extension
批准号:
7172261
负责人:
RICHARD Ashley HURT
金额:
$27.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2008-01-31
关键词:
AddressAgricultureAntimicrobial ResistanceBacteriaBacterial GenomeBacteriophagesBiological AssayBiological WarfareCategoriesClinicalCommunitiesCompatibleComplementComputer Systems DevelopmentConditionDNADataDetectionDevelopmentDiagnosisDiagnosticDiarrheaDiseaseDisease OutbreaksDustElementsEnvironmentEnzymesEpidemicEquipmentFeverFluorescenceGene TargetingGenesGenotypeGoalsGuidelinesHomologous GeneHot SpringsHumanIn VitroLabelMarketingMethodsMolecularNucleotidesNumbersOrganismPathogen detectionPathogenesisPhasePolymerase Chain ReactionPopulationPositioning AttributePreparationPrimer ExtensionProceduresProcessProkaryotic CellsProtocols documentationProtozoaRangeReactionReagentReportingResearchResearch PersonnelResearch Project GrantsResistance profileSamplingScienceSequence AlignmentSimulateSingle-Stranded DNASpecificitySpecimenSpeedStandards of Weights and MeasuresSurfaceSyndromeSystemTechniquesTechnologyTemperatureTestingThermus thermophilusToxinTraining ProgramsTubeUrinationVacuumVibrioVibrio choleraeVirusWorkbasebiodefensebiosafety level 2 facilitydesigndideoxynucleotideemergency service responderfoodborne pathogenfungushelicasemicrobialnovelpathogenpathogenic bacteriarapid detectionresearch clinical testingresistance factorssoil samplingwater samplingwater testing
中文摘要
项目概述-提出一种新的基于综合征的诊断系统,用于快速检测和识别B类和C类优先病原体。第一阶段将重点研究霍乱弧菌基因和来自类似病原体的基因。该技术依赖于解旋酶驱动的迭代引物延伸反应(HDIE),该反应使用等温、多路目标扩增来产生短的、标记的单链DNA产物,其序列代表样品DNA。这些反应产物非常适合与固定在微阵列上的短探针杂交,从而提供样品中任何病原体的基因鉴定。第二阶段将把这项技术扩展到广泛的B类和C类优先病原体。这项研究的成功完成将产生一个基于综合征的诊断系统,该系统可以在大量候选样本中识别出一种或多种病原体。该技术将是等温的,需要最少的设备进行初始反应,使其在生物战攻击或疫情爆发时对第一响应者有用。
英文摘要
DESCRIPTION (provided by applicant): Project Summary - A new syndrome-based diagnostic system for rapid detection and identification of category B and C priority pathogens is proposed. Phase 1 will focus on V. cholerae genes and genes from similar pathogens. The technique relies upon a helicase-driven iterative primer extension reaction (HDIE) that uses isothermal, multiplexed target amplification to produce short, labeled, single-stranded DNA products with sequences representative of the sample DNA. These reaction products are ideal for hybridization to short probes immobilized on microarrays, thus providing gene identification of any pathogen in the sample. Phase II will expand the technique to a wide variety of category B and C priority pathogens. Successful completion of the research will result in a syndrome-based diagnostic system that can identify one or more pathogens in a sample among a large number of candidates. The technique will be isothermal and require minimum equipment for the initial reactions, making it useful to first responders in a biowarfare attack or an outbreak.
HDIE relies on the fact that there are a large number of regions in any gene that are missing one of the four DNA bases over a span of 12 to 40 bases. HDIE primers are designed to be complementary to a section of the target DNA immediately adjacent to the 3' end of one of these void regions. Once the primer is annealed to the target DNA, the extension reaction proceeds from the 3' end of the primer using the region lacking either A, T, G, or C as the template. When the first occurrence of the missing base is encountered the extension reaction is terminated by incorporation of a complementing dideoxynucleotide. DNA helicases separate the extension reaction products from the template molecules, allowing iterative non-exponential target amplification. The HDIE products can be hybridized to microarray probes and detected using conventional fluorescence methods. The fact that the reaction is terminated after a very short extension, along with fact that amplification is linear rather than exponential, allows hundreds of primers to be present in a single reaction tube.
Although the HDIE approach is designed to overcome difficulties specific to parallel pathogen diagnosis, it can be extended to many applications that tap into the lucrative molecular diagnostics market, including foodborne pathogen detection, agricultural and veterinary testing, water testing, and clinical testing. In 2005, the global market for molecular diagnostics is expected to be $6.5 billion, or about 3.3% of the total diagnostics market and approximately 14% of the in vitro diagnostic market. The molecular diagnostics market is forecast to increase to $12 billion by 2010 and $35 billion by 2015.
Relevance - The proposed research directly addresses the need for a syndrome-based assay that can rapidly identify' the pathogen or pathogens responsible for disease in case of a biowarfare attack or a major outbreak.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ultra-Sensitive Molecular Diagnostic for Borrelia Species
-
批准号:7481939
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2008
-
负责人:RICHARD Ashley HURT
-
依托单位:
Analysis of Environmental Mycobacterium Ulcerans
-
批准号:7219178
-
项目类别:
-
资助金额:$9.88万
-
财政年份:2007
-
负责人:RICHARD Ashley HURT
-
依托单位:
Bioagent Characterization by Iterative Extension
-
批准号:7051529
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2006
-
负责人:RICHARD Ashley HURT
-
依托单位:
Specific Diagnostic for Members of Genus Mycobacterium
-
批准号:6933252
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:RICHARD Ashley HURT
-
依托单位:
SNP Detection with Unlabeled, Unamplified Target DNA
-
批准号:6753502
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:RICHARD Ashley HURT
-
依托单位:
SNP Detection with Unlabeled, Unamplified Target DNA
-
批准号:6643759
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2002
-
负责人:RICHARD Ashley HURT
-
依托单位:
海外基金